Stocks
Organon & Co.OGN
NYSEHealthcarePharmaceuticals$6.35+0.32%
A global healthcare company focused on women's health, offering a portfolio of prescription therapies and medical devices. Spun off from Merck in 2021, Organon operates in over 140 markets and is tracked for its biosimilars pipeline and established contraceptive brands.
Market Cap: $1.7B52W Range: $6.18 – $15.88
Congressional Interest in Organon & Co. (OGN)
6 members of Congress have disclosed 16 trades in Organon & Co. (OGN), a Healthcare company. The buy/sell breakdown shows 3 purchases versus 13 sales, indicating net selling pressure from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
16
Unique Politicians
6
Buys
3
Sells
13
Who in Congress Is Trading OGN?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2025-07-10 | GARY C. PETERS | sell | $1K – $15K |
| 2024-08-05 | Rohit Khanna | sell | $1K – $15K |